A Study to Assess the Accuracy of Magnetocardiography (MCG) to Diagnose True Ischemia in Patients With Chest Pain in the ED
Launched by MAYO CLINIC · Mar 30, 2023
Trial Information
Current as of July 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Hypothesis: MCG can accurately, and in real-time, identify an acute coronary syndrome for patients presenting to the emergency department (ED) with chest pain and is faster than current practice.
Aims, purpose, or objectives: Our primary objective is to measure the diagnostic accuracy of the Mesuron Avalon-H90 MCG device to detect ACS (unstable angina, NSTEMI) in Emergency Department patients who present with acute chest pain when compared to the current goal standard.
Our secondary objectives are as follows:
* To study the ability of MCG to rule in or rule out ACS in real-time. We will ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients presenting to the ED with acute chest pain when an ACS is on the differential diagnosis.
- • Patient willing and able to give informed consent.
- Exclusion Criteria:
- • ST elevation \> 1 mm on any two contiguous ECG leads.
- • Hemodynamic instability (SBP \>220 or \<80, HR \>160).
- • Pregnant patients.
- • Incarcerated patients (FMC patients).
- • Patients with a pacemaker or defibrillator.
- • Metal implants in the body (that are not MRI safe).
- • Patients that are unable to lie down in the MCG machine or stay still.
- • Patients who are unable to understand the informed consent process (ex: non-English speakers without an available interpreter, cognitive delay).
- • Patients without the capacity to provide written informed consent
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Sara Hevesi, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials